CMTA-STAR Research for Demyelinating Forms of CMT

…in-depth conversation about STAR please reach out to Jeana Sweeney, Chief Engagement and Gifts Officer: jeana@cmtausa.org. Support CMT Research READ MORE ABOUT CMTA-STAR RESEARCH FOR DEMYELINATING TYPES OF CMT CMT

CMT Awareness Month 2020: Be a Champion

…awareness and funds for the CMTA: Mary Louie, CMTA Branch Leader, Walk 4 CMT Leader & Fundraiser LEARN MORE “For Our Future Generations” Why We Walk 4 CMT: Asher Norris,…

CMTA-STAR Awards Researcher $98,985 For CMT1A Project

…and CMT 1X (GJB1). It is estimated that CMT affects 3+ million people worldwide, regardless of gender, race, or ethnicity. More information can be found at https://www.cmtausa.org/understanding-cmt/what-is-cmt About the CMTA…

STAR: Our CMT Research Strategy

…challenges. Just click here. Learn more about how the CMT is accelerating research for Demyelinating and Axonal forms of CMT READ MORE: DEMYELINATING CMT ⟶ READ MORE: AXONAL CMT ⟶…

CMTA Staff

…Accelerate Research (STAR) and STAR Advisory Board, a group of 30 of the world’s leading CMT clinicians and scientists charged with shaping and delivering the CMTA’s research strategies. The CMTA…

2021_Spring_CMTA_Report

CMT2F, CMT2K, CMT4A and CMT4C, utilizing a number of different technologies, including AAV delivery, gene silencing, gene replacement and genome editing using CRISPR-Cas9 and antisense oligonucleotides (ASOs). The CMTA continues…

CMT2A Research

CMT2A CMT2A is caused by dominant mutations in Mitofusin 2 (MFN2). The STAR team has developed two excellent rat models for CMT2A which are being made available to the research…